Overall and event-free survival are not improved by the use of myelo-ablative therapy following intensified chemotherapy in previously untreated multiple myelom patients: a prospective randomized phase III study

C.M. Segeren; P. Sonneveld; B. van der Holt; E. Vellenga; A.J. Croockewit; G.E. Verhoef; J.J. Cornelissen; M.R. Schaafsma; M.H.J. van Oers; P.W. Wijermans; W.E. Fibbe; S. Wittebol; H.C. Schouten; M. van Marwijk Kooy; D.H. Biesma; J.W. Baars; R. Slater; M.M. Steijaert; I. Buijt; H.M. Lokhorst

Overall and event-free survival are not improved by the use of myelo-ablative therapy following intensified chemotherapy in previously untreated multiple myelom patients: a prospective randomized phase III study

Translated title of the contribution: Overall and event-free survival are not improved by the use of myelo-ablative therapy following intensified chemotherapy in previously untreated multiple myelom patients: a prospective randomized phase III study

C.M. Segeren, P. Sonneveld, B. van der Holt, E. Vellenga, A.J. Croockewit, G.E. Verhoef, J.J. Cornelissen, M.R. Schaafsma, M.H.J. van Oers, P.W. Wijermans, W.E. Fibbe, S. Wittebol, H.C. Schouten, M. van Marwijk Kooy, D.H. Biesma, J.W. Baars, R. Slater, M.M. Steijaert, I. Buijt, H.M. Lokhorst

Hematology/Van Creveldclinic

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Overall and event-free survival are not improved by the use of myelo-ablative therapy following intensified chemotherapy in previously untreated multiple myelom patients: a prospective randomized phase III study
Original language	Undefined/Unknown
Pages (from-to)	2144-2151
Number of pages	8
Journal	Blood
Volume	101
Issue number	6
Publication status	Published - 2002

Cite this

Segeren, C. M., Sonneveld, P., van der Holt, B., Vellenga, E., Croockewit, A. J., Verhoef, G. E., Cornelissen, J. J., Schaafsma, M. R., van Oers, M. H. J., Wijermans, P. W., Fibbe, W. E., Wittebol, S., Schouten, H. C., van Marwijk Kooy, M., Biesma, D. H., Baars, J. W., Slater, R., Steijaert, M. M., Buijt, I., & Lokhorst, H. M. (2002). Overall and event-free survival are not improved by the use of myelo-ablative therapy following intensified chemotherapy in previously untreated multiple myelom patients: a prospective randomized phase III study. Blood, 101(6), 2144-2151.

@article{53ad4968341f47cb9cc708c4f053da86,

title = "Overall and event-free survival are not improved by the use of myelo-ablative therapy following intensified chemotherapy in previously untreated multiple myelom patients: a prospective randomized phase III study",

author = "C.M. Segeren and P. Sonneveld and {van der Holt}, B. and E. Vellenga and A.J. Croockewit and G.E. Verhoef and J.J. Cornelissen and M.R. Schaafsma and {van Oers}, M.H.J. and P.W. Wijermans and W.E. Fibbe and S. Wittebol and H.C. Schouten and {van Marwijk Kooy}, M. and D.H. Biesma and J.W. Baars and R. Slater and M.M. Steijaert and I. Buijt and H.M. Lokhorst",

year = "2002",

language = "Undefined/Unknown",

volume = "101",

pages = "2144--2151",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "6",

}

Segeren, CM, Sonneveld, P, van der Holt, B, Vellenga, E, Croockewit, AJ, Verhoef, GE, Cornelissen, JJ, Schaafsma, MR, van Oers, MHJ, Wijermans, PW, Fibbe, WE, Wittebol, S, Schouten, HC, van Marwijk Kooy, M, Biesma, DH, Baars, JW, Slater, R, Steijaert, MM, Buijt, I & Lokhorst, HM 2002, 'Overall and event-free survival are not improved by the use of myelo-ablative therapy following intensified chemotherapy in previously untreated multiple myelom patients: a prospective randomized phase III study', Blood, vol. 101, no. 6, pp. 2144-2151.

Overall and event-free survival are not improved by the use of myelo-ablative therapy following intensified chemotherapy in previously untreated multiple myelom patients: a prospective randomized phase III study. / Segeren, C.M.; Sonneveld, P.; van der Holt, B. et al.
In: Blood, Vol. 101, No. 6, 2002, p. 2144-2151.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Overall and event-free survival are not improved by the use of myelo-ablative therapy following intensified chemotherapy in previously untreated multiple myelom patients: a prospective randomized phase III study

AU - Segeren, C.M.

AU - Sonneveld, P.

AU - van der Holt, B.

AU - Vellenga, E.

AU - Croockewit, A.J.

AU - Verhoef, G.E.

AU - Cornelissen, J.J.

AU - Schaafsma, M.R.

AU - van Oers, M.H.J.

AU - Wijermans, P.W.

AU - Fibbe, W.E.

AU - Wittebol, S.

AU - Schouten, H.C.

AU - van Marwijk Kooy, M.

AU - Biesma, D.H.

AU - Baars, J.W.

AU - Slater, R.

AU - Steijaert, M.M.

AU - Buijt, I.

AU - Lokhorst, H.M.

PY - 2002

Y1 - 2002

M3 - Article

SN - 0006-4971

VL - 101

SP - 2144

EP - 2151

JO - Blood

JF - Blood

IS - 6

ER -